Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
Status:
Completed
Trial end date:
2010-09-17
Target enrollment:
Participant gender:
Summary
A study to assess the safety, tolerability, and single dose pharmacokinetics of a marketed
drug in pediatric subjects with migraines.
After completion of a portion of the study (Panels A and B), a regulatory agency issued an
amended request that the 12-17 year old age group studied should include a similar number of
male and female subjects. Therefore, the study was amended to add an additional panel of
subjects (Panel C) to ensure gender balance specifically in this age group.